Cargando…
Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience
At the Nanomedicine Innovation Center (NICE) at the Erasmus MC in Rotterdam, we have approached the treatment of cancer by starting with a vision of first establishing a platform that enables us to overcome the low levels of drugs delivered to tumors and the issue of dose-limiting toxicity. Showing...
Autores principales: | Amin, Mohamadreza, Seynhaeve, Ann L. B., Sharifi, Majid, Falahati, Mojtaba, ten Hagen, Timo L. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607095/ https://www.ncbi.nlm.nih.gov/pubmed/36297598 http://dx.doi.org/10.3390/pharmaceutics14102165 |
Ejemplares similares
-
Enhanced Specificity and Drug Delivery in Tumors by cRGD - Anchoring Thermosensitive Liposomes
por: Dicheva, Bilyana M., et al.
Publicado: (2015) -
Hyperthermia and Temperature-Sensitive Nanomaterials for Spatiotemporal Drug Delivery to Solid Tumors
por: Amin, Mohamadreza, et al.
Publicado: (2020) -
Drug transport kinetics of intravascular triggered drug delivery systems
por: ten Hagen, Timo L. M., et al.
Publicado: (2021) -
Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response
por: Saeed, Mesha, et al.
Publicado: (2019) -
Explaining chemical clues of metal organic framework-nanozyme nano-/micro-motors in targeted treatment of cancers: benchmarks and challenges
por: Falahati, Mojtaba, et al.
Publicado: (2022)